For 4Q16, $WDC expects revenue to be $2.6-2.7Bil. Excluding the impact of interest expense from debt financing related to the $SNDK acquisition, company expects non-GAAP EPS to be $1.00-1.10. Non-GAAP GM is expected to be up from 3Q16. OpEx is expected to be about $475MM for 4Q16.
For 2017, $ENDP expects US Generics base business revenue decline to be similar to 2016 or in the low 30% range. Generics segment sales are expected to decline in the high-single to low-double digit range. In US Generics business, $ENDP estimates to realize approx. $75MM in annual net savings and launch at least 20 products in 2017.
$EQIX agreed for the purchase of ICT-Center AG, Zurich's data center operating business in Zurich, Switzerland for less than $5MM. The agreement was signed on Feb. 1, 2017 and the acquisition is expected to close sometime in early April 2017.
$TGT is currently operating in a challenging environment where many
retailers are closing stores, exiting markets and cutting costs. This
contraction will create opportunities for $TGT to pick up market share over the
long-term but aggressive promotional activity will create pressure on the
business in the near term.